---
title: "John Powers III Named Permanent Director of NIAID"
id: "stat-news-4-stat-niaid-acting-head-john-powers-iii-appointed-as-the-permanent-director"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-4-stat-niaid-acting-head-john-powers-iii-appointed-as-the-permanent-director"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/11/16/john-powers-appointed-niaid-director/?utm_campaign=rss"
published_at: "2026-11-16T17:47:11.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# John Powers III Named Permanent Director of NIAID
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-4-stat-niaid-acting-head-john-powers-iii-appointed-as-the-permanent-director
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/11/16/john-powers-appointed-niaid-director/?utm_campaign=rss)
- **Published At:** 2026-11-16T17:47:11.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- John Powers III, who had been serving as acting director, was appointed permanent director of the **National Institute of Allergy and Infectious Diseases**; the agency announced the move on Nov. 16, 2026. - NIAID lacked a permanent director since March 2025, when Jeanne Marrazzo was removed from the post, and the institute has seen leadership churn since that time. - Powers has been at NIAID since 1999 and is a physician-scientist with roles focused on clinical research; the source noted his long tenure but did not provide a detailed CV or list of specific prior positions. - The article reported that Powers had been acting director since June 2026; the source did not include details on the selection process, internal deliberations, or formal nomination paperwork. - The piece placed the appointment in the context of heightened scrutiny of the institute under the second Trump administration, including presidential hostility toward Anthony Fauci and unproven accusations about China-funded research’s role in SARS-CoV-2. - The story recounted recent turbulence at NIAID: Jeffery Taubenberger served as acting director after Marrazzo’s exit and later stepped down unexpectedly; other senior leaders were reassigned or asked to resign, according to the source. - STAT reported the appointment as an exclusive to its STAT+ subscribers; the publicly available portion of the article stopped short of providing additional comments from Powers, NIH officials, or external stakeholder reactions. - The source did not report on Powers’s strategic priorities for NIAID, an implementation timeline, or any immediate organizational changes tied to the appointment. - The article listed the reporter (Anil Oza) and the publication date (Nov. 16, 2026); it did not provide direct quotes from Powers or from NIH announcing materials in the freely available excerpt. - Remaining open questions documented by the source include the absence of disclosed nomination paperwork, lack of detailed biographical specifics in the public excerpt, and no reported plans for next steps at NIAID beyond the announcement.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/11/16/john-powers-appointed-niaid-director/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/16/john-powers-appointed-niaid-director/?utm_campaign=rss) [Clinical trials](https://www.statnews.com/topic/clinical-trials/) [Cancer](https://www.statnews.com/topic/cancer/) [health care](https://www.statnews.com/topic/health-care/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [Midterms 2026](https://www.statnews.com/midterms-2026-health-care-policy-issues/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Trust in Science](https://www.statnews.com/trust-in-science/) * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Madness 2027](https://www.statnews.com/feature/stat-madness/apply/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) China's Biotech Powerhouse 25 We ranked the 25 most valuable publicly traded Chinese drugmakers [ See the list ](https://www.statnews.com/china-biotech-index-powerhouse-25/) [STAT Plus](https://www.statnews.com/stat-plus/)[Politics](https://www.statnews.com/category/politics/) # NIAID acting head John Powers III appointed as the permanent director ## NIH’s infectious diseases branch had been without a leader since March 2025 * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/16/john-powers-appointed-niaid-director/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2025/01/AdobeStock_419260711_Editorial_Use_Only-645x645.jpeg) Adobe ![](https://www.statnews.com/wp-content/uploads/2024/09/Anil-Oza-avatar-round-80x80.png) By [Anil Oza](https://www.statnews.com/staff/anil-oza/) Nov. 16, 2026 General Assignment Reporter ![](https://www.statnews.com/wp-content/uploads/2024/09/Anil-Oza-avatar-round-80x80.png) [Anil Oza](https://www.statnews.com/staff/anil-oza/) 1. [](https://x.com/@AnilOza16 "X") anil.oza@statnews.com Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. The acting director of the National Institute of Allergy and Infectious Diseases, John Powers III, will become the permanent director, the agency announced Monday. NIAID has been without a permanent director since March 2025, when the Trump administration [ousted Jeanne Marrazzo](https://www.statnews.com/2025/09/04/nih-whistleblower-complaints-research-grants-flu-vaccine-jeanne-marrazzo/). Powers has been serving in an acting capacity [since June](https://www.statnews.com/2026/06/09/niaid-acting-director-john-powers-replaces-taubenberger/). A physician-scientist, Powers has worked with NIAID since 1999 in several roles focused on clinical research. Advertisement ![John H. Powers III, M.D.](https://www.statnews.com/wp-content/uploads/2026/11/john-powers-june-2026.jpg)John Powers III has been named the permanent director of the National Institute of Allergy and Infectious Diseases.NIAID The second Trump administration has brought a renewed spotlight to the infectious disease institute, in large part because of the president’s ire for former director Anthony Fauci, and because of unsubstantiated accusations that research funded by an institute in China played a role in creating the SARS-CoV-2 virus. It has also seen tumult in its leadership. After Marrazzo was ousted, Jeffery Taubenberger was appointed acting director. He [unexpectedly stepped down](https://www.statnews.com/2026/05/21/nih-niaid-jeffrey-taubenberger-exit/), and several other leaders at NIAID were [reassigned to other institutes or asked to resign](https://www.nature.com/articles/d41586-026-01558-w). STAT+ Exclusive Story Already have an account? [Log in](https://www.statnews.com/login/) ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-breaker-bg.png) [ ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo-white.svg) ](https://www.statnews.com/stat-plus/) ## This article is exclusive to STAT+ subscribers ### Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+. Already have an account? [Log in](https://www.statnews.com/login/) Individual plans Group plans Monthly $39 Totals $468 per year [$39/month](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) Totals $468 per year Starter $30 for 3 months, then $399/year [$30 for 3 months](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) Then $399/year Annual $399 Save 15% [$399/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) Save 15% 11+ Users Custom Savings start at 25%! [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) Savings start at 25%! 2-10 Users $300 Annually per user [$300/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) $300 Annually per user [View All Plans](https://www.statnews.com/stat-plus/) [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [infectious disease](https://www.statnews.com/topic/infectious-disease/), [NIH](https://www.statnews.com/topic/nih/), [Policy](https://www.statnews.com/topic/policy/), [STAT+](https://www.statnews.com/topic/stat-plus/), [Vaccines](https://www.statnews.com/topic/vaccines/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2024/09/Anil-Oza-avatar-round-80x80.png) [Anil Oza](https://www.statnews.com/staff/anil-oza/) 1. [](https://x.com/@AnilOza16 "X") 2. General Assignment Reporter 1. [](https://x.com/@AnilOza16 "X") 2. Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/Morning-Rounds-Logo-Black-640x295.png) ### Newsletter Understand how science, health policy, and medicine shape the world every day Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/11/AdobeStock_2158931352-80x80.jpeg) [Medical school should start after students take the Step 1 exam](https://www.statnews.com/2026/11/16/medical-school-step-1-exam-redesign-proposal/) 2. ![](https://www.statnews.com/wp-content/uploads/2020/07/AdobeStock_335879672-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Apple and OpenEvidence launch experimental health chat app](https://www.statnews.com/2026/11/15/apple-openevidence-launch-health-chat-app-experiment-ai/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/11/AdobeStock_331634765-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Versant, Lilly put $100 million behind new startup aimed at solving one of gene therapy’s thorniest issues](https://www.statnews.com/2026/11/16/versant-lilly-put-100-million-behind-new-startup-aimed-at-solving-one-of-gene-therapys-thorniest-issues/) 4. ![](https://www.statnews.com/wp-content/uploads/2024/09/GettyImages-1237273640-1-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA rejects lung cancer treatment ivonescimab from Summit Therapeutics](https://www.statnews.com/2026/11/15/fda-rejects-ivonescimab-lung-cancer-treatment-summit-therapeutics/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/11/GettyImages-2298594379-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [With Stephen Miller as chief of staff, Kennedy’s MAHA agenda is reinvigorated](https://www.statnews.com/2026/11/16/stephen-miller-chief-of-staff-boosts-power-of-kennedy-maha/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/10/STATatHLTH_Wordpress_CalendarImage-80x80.jpg) STAT@hlth. A Dose of Reality on EHRs and AI In-person Nov 18 ](https://www.statnews.com/event/stathlth-a-dose-of-reality-on-ehrs-and-ai/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/2026ASH_Wordpress_CalendarImage-80x80.jpg) STAT@ASH: Medicine’s Bleeding Edge New Orleans, LA Dec 13 ](https://www.statnews.com/event/stat-at-ash-meeting-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/BTE2027_Wordpress_CalendarImage-80x80.jpg) 2027 Breakthrough Summit East New York City, NY Mar 18 ](https://www.statnews.com/event/2027-stat-breakthrough-summit-east/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2026/11/AdobeStock_6400491-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA warns GLP-1 drugs carry potential risk of rare eye condition](https://www.statnews.com/2026/11/09/glp-1-drugs-potential-risk-rare-eye-condition-naion-fda/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/10/AdobeStock_391451620_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drug](https://www.statnews.com/pharmalot/2026/11/10/former-lilly-rep-claims-she-was-fired-for-complaining-about-marketing-of-mounjaro-diabetes-drug/) 3. ![](https://www.statnews.com/wp-content/uploads/2019/09/AP_060324030695-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA approves novel Bayer drug to reduce recurrence of stroke](https://www.statnews.com/2026/11/09/cardiovascular-stroke-recurrence-bayer-drug-fda-approval/) 4. ![](https://www.statnews.com/wp-content/uploads/2024/09/GettyImages-1237273640-1-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA rejects lung cancer treatment ivonescimab from Summit Therapeutics](https://www.statnews.com/2026/11/15/fda-rejects-ivonescimab-lung-cancer-treatment-summit-therapeutics/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/05/AP26023803702193-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Oura’s acquisition of health tech startup raises conflict-of-interest questions for Eli Lilly, experts say](https://www.statnews.com/2026/11/13/oura-acquisition-counsel-health-eli-lilly/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Health Care Inc. Newsletter Health Care Inc. Newsletter November 16, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Suing Joe the Plumber and Microsoft, and diminishing raises ](https://www.statnews.com/2026/11/16/providers-sue-employers-to-collect-payment-health-insurance-costs-climb/) By [Bob Herman](https://www.statnews.com/staff/bob-herman/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Politics Politics November 16, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: With Stephen Miller as chief of staff, Kennedy’s MAHA agenda is reinvigorated ](https://www.statnews.com/2026/11/16/stephen-miller-chief-of-staff-boosts-power-of-kennedy-maha/) By [Chelsea Cirruzzo](https://www.statnews.com/staff/chelsea-cirruzzo/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Politics Politics November 13, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Enforcement of stringent Medicaid work requirements delayed for six months ](https://www.statnews.com/2026/11/13/medicaid-work-requirements-implementation-delayed-six-months/) By [John Wilkerson](https://www.statnews.com/staff/john-wilkerson/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Politics Politics November 13, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Democrats coalesce around ‘Medicare for More,’ ‘Medikids’ proposals ](https://www.statnews.com/2026/11/13/democrats-eye-medicare-for-more-vs-medicare-for-all/) By [John Wilkerson](https://www.statnews.com/staff/john-wilkerson/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Health Health November 13, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Senators introduce bill to curb conflicts of interest on preventive care panel ](https://www.statnews.com/2026/11/13/uspstf-preventive-care-panel-senators-target-conflicts-of-interest/) By [Chelsea Cirruzzo](https://www.statnews.com/staff/chelsea-cirruzzo/) #### Subscriber Picks 1. ### [ A new tactic in the war over out-of-network bills: Health care providers are suing employers ](https://www.statnews.com/2026/11/11/no-surprises-act-phi-health-air-ambulance-sues-employers/) By [Bob Herman](https://www.statnews.com/staff/bob-herman/) 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/
## Related Clinical Research

- [Exercise Prescriptions for Concussion Recovery: An Urgent Call to Action](https://medichelpline.com/clinical-feed/stat-news-2-opinion-more-doctors-should-prescribe-exercise-after-a-concussion.md)
- [Merck partners with Isomorphic Labs to discover small-molecule oncology candidates](https://medichelpline.com/clinical-feed/stat-news-3-stat-merck-isomorphic-labs-partner-to-develop-oncology-drug-candidates.md)
- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)
- [Ultra-processed foods linked to MRI signs of vascular brain injury in middle-aged adults](https://medichelpline.com/clinical-feed/medical-news-today-0-ultra-processed-foods-may-be-harming-brain-health-in-otherwise-healthy-adults.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.